NYSE · Diagnostics & Research
Charles River Laboratories (CRL)
$314.32
-4.15%
51
In band
Moving averages
SMA 200$226.46+38.80%
Company profile
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$16.33B
P/E ratio370.45
EPS$0.92
Beta1.338
Dividend yield0.00%
52-week high$379.63
52-week low$146.20
Similar stocks in Diagnostics & Research
RSI alerts for CRL
An email when CRL closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 7:00 AM EST